# Fenoldopam for Prevention of Acute Kidney Injury

Study · id `cardio:ct-nct01690832` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01690832](<https://clinicaltrials.gov/study/NCT01690832>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01690832

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

## Technical summary

Registry record NCT01690832. Randomized; single masking; primary purpose treatment. Start 2012-09 (registry gives no type); primary completion 2013-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 100 participants (planned count; ClinicalTrials.gov record NCT01690832, source copy `cardio:ctgov-nct01690832-2012-09-24`, retrieved 2026-10-26)
- Start date: 2012-09 (registry gives no type) (ClinicalTrials.gov record NCT01690832, source copy `cardio:ctgov-nct01690832-2012-09-24`, retrieved 2026-10-26)
- Primary completion: 2013-12 (anticipated) (ClinicalTrials.gov record NCT01690832, source copy `cardio:ctgov-nct01690832-2012-09-24`, retrieved 2026-10-26)
- Completion: 2014-12 (anticipated) (ClinicalTrials.gov record NCT01690832, source copy `cardio:ctgov-nct01690832-2012-09-24`, retrieved 2026-10-26)
- Countries: Italy (ClinicalTrials.gov record NCT01690832, source copy `cardio:ctgov-nct01690832-2012-09-24`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01690832-2012-09-24`, retrieved 2026-10-26)

## The registry's words

- Brief title: Fenoldopam for Prevention of Acute Kidney Injury
- Acronym: FANCY
- Condition: Coronary Artery Disease
- Intervention (Drug): standard saline infusion
- Intervention (Drug): fenoldopam infusion
- Lead sponsor: University of Roma La Sapienza
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: University of Roma La Sapienza (`cardio:org-university-of-roma-la-sapienza`)

## Provenance

Content hash: 28f149a7effa9fa707fc93ce8c1479d110c14fdc47937e83360c8638e4a1e683
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
